Korporacja KGL S.A. (KGL.WA)
Stare Babice, PL
Korporacja KGL S.A. functions as a significant supplier of thermoplastic polymer granules, catering to both domestic Polish and international markets. The company's diverse product catalog includes various types of polystyrene, such as expandable, low-impact, and high-impact grades, alongside styrene-butadiene copolymer. Its polyolefin offerings span numerous polypropylene varieties, including homopolymer, block copolymer, random copolymer, and metallocene polypropylene, as well as a range of polyethylenes like high-density, medium-density, low-density, and metallocene polyethylene, plus ethylene vinyl acetate copolymer. KGL also provides an extensive selection of engineering plastics, featuring polyoxymethylene polyacetal, polycarbonate, polymethyl methacrylate, polyamide, acrylonitrile-styrene-acrylic terpolymer, styrene-acrylonitrile copolymer, acrylonitrile-butadiene-styrene terpolymer, PC/ABS blends, filled polypropylenes, phenylene polysulphide, and polyvinylidene fluoride. Moreover, specialized polymers are available, such as electrically conductive, thermally conductive, thermally resistant, and wear-resistant thermoplastic composites, along with high specific gravity and various filled and reinforced polymers. In the elastomers category, the company supplies thermoplastic vulcanizate, styrene/ethylene-butylene/styrene terpolymers, and styrene/butadiene/styrene copolymer. Beyond raw polymers, KGL distributes a variety of additives, including dyes, UV stabilizers, antistatic agents, antiblocks, special modifiers, and chalk fillers. The company further extends its services to encompass the design and construction of molds for thermoforming and injection systems. Additionally, it manufactures plastic food packaging for the fast-moving consumer goods (FMCG) industry and produces the necessary tooling for both thermoforming and injection production processes. Korporacja KGL S.A. was founded in 1992 and maintains its headquarters in Klaudyn, Poland.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.92% | +4.76% | +8.91% | -5.17% | +2.80% | -20.29% | -20.00% | -38.03% | -50.78% | -42.04% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-0.7% Q1'26: +11.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-383.3% Q1'26: +122.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+2.3% ★ Q1'26: +7.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-1.4% Q1'26: +3.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-3.3% Q1'26: +4.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.2% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×6.17× Q1'26: 2.74× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
343.14M
est: 337.10M (+1.8%)
|
375.58M
est: 376.00M (-0.1%)
|
392.37M
est: 399.70M (-1.8%)
|
379.96M
est: 368.30M (+3.2%)
|
575.84M
est: 578.00M (-0.4%)
|
652.04M
est: 674.35M (-3.3%)
|
562.59M
est: 615.50M (-8.6%)
|
531.55M
est: 656.70M (-19.1%)
|
527.72M
est: 691.00M (-23.6%)
|
| EBITDA |
33.27M
est: 26.99M (+23.3%)
|
25.83M
est: 30.10M (-14.2%)
|
37.84M
est: 32.00M (+18.3%)
|
40.46M
est: 29.48M (+37.2%)
|
37.36M
est: 46.27M (-19.3%)
|
24.19M
est: 53.98M (-55.2%)
|
67.75M
est: 49.27M (+37.5%)
|
37.94M
est: 43.89M (-13.6%)
|
21.32M
est: 46.18M (-53.8%)
|
| EBIT |
21.46M
est: 10.27M (+108.9%)
|
10.90M
est: 11.46M (-4.9%)
|
19.22M
est: 12.18M (+57.8%)
|
18.31M
est: 11.22M (+63.1%)
|
11.62M
est: 17.62M (-34.1%)
|
-3.12M
est: 20.55M (-115.2%)
|
40.01M
est: 18.76M (+113.3%)
|
9.42M
est: 11.79M (-20.2%)
|
-7.61M
est: 12.41M (-161.3%)
|
| Net Income |
15.19M
est: 15.19M (0.0%)
|
6.15M
est: 5.29M (+16.4%)
|
12.18M
est: 9.91M (+22.9%)
|
11.18M
est: 11.69M (-4.4%)
|
5.25M
est: 10.44M (-49.7%)
|
-16.97M
est: 150.0K (-11,413.9%)
|
18.30M
est: 37.46M (-51.1%)
|
-3.79M
est: 26.11M (-114.5%)
|
-18.39M
est: 27.75M (-166.3%)
|
| SGA |
33.98M
est: 39.68M (-14.4%)
|
40.42M
est: 44.26M (-8.7%)
|
49.09M
est: 47.05M (+4.4%)
|
50.47M
est: 43.35M (+16.4%)
|
58.98M
est: 68.03M (-13.3%)
|
65.54M
est: 79.37M (-17.4%)
|
66.22M
est: 72.45M (-8.6%)
|
71.78M
est: 78.30M (-8.3%)
|
74.13M
est: 82.39M (-10.0%)
|
| EPS |
2.12
est: 2.15 (-1.4%)
|
0.86
est: 0.75 (+15.0%)
|
1.71
est: 1.40 (+22.0%)
|
1.56
est: 1.65 (-5.7%)
|
0.74
est: 1.48 (-49.9%)
|
-2.41
est: 0.02 (-11,459.9%)
|
2.59
est: 5.30 (-51.1%)
|
-0.54
est: 3.70 (-114.6%)
|
-2.61
est: 3.93 (-166.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-03 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-02 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-01 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-25 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Krzysztof Stanislaw Gromkowski | President of the Management Board | 827.0K | male |
| Adam Skibinski | Vice President of the Management Board | 826.0K | male |
| Ireneusz Strzelczak | Member of the Supervisory Board | 826.0K | male |
| Rafal Cybulski | Vice President of the Management Board | 826.0K | male |
| Piotr Mierzejewski | Chief Financial Officer & Vice President of the Management Board | 545.0K | male |
| Katarzyna Lipowska | Chief Accountant | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KGL.WA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
